Brief: Inhalerx Says Matthew Golden Resigns As Chief Executive Officer
29/12/2021 01:35
Dec 29 (Reuters) - Inhalerx:
* MATTHEW GOLDEN RESIGNS AS CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nASX8WPly1
Further company coverage: IRX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval